English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Acute bacterial meningitis is a serious disease and a medical emergency with a high rate of mortality and risk of neurological sequels, especially among young children [1, 2]. Additionally, the disease can have negative impacts on cerebral blood perfusion, resulting in hypoxia and cell death. It requires an efficient therapy that may rapidly sterilize the central nervous system and limit the inflammatory response [3]. Furthermore, the mortality rate attributed to pneumococcal meningitis is significantly higher (30%) compared to meningococcal meningitis (7%) [1].

Pneumococcal Meningitis Among Children in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: Three Case Reports